NORTHERN TRUST CORP - LANTERN PHARMA INC ownership

LANTERN PHARMA INC's ticker is LTRN and the CUSIP is 51654W101. A total of 24 filers reported holding LANTERN PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.06 and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of LANTERN PHARMA INC
ValueSharesWeighting
Q3 2023$42,942
-39.5%
12,5930.0%0.00%
Q2 2023$71,025
+16.4%
12,593
-0.3%
0.00%
Q1 2023$60,998
-20.0%
12,6290.0%0.00%
Q4 2022$76,279
+27.1%
12,6290.0%0.00%
Q3 2022$60,000
-16.7%
12,6290.0%0.00%
Q2 2022$72,000
-20.0%
12,6290.0%0.00%
Q1 2022$90,000
-10.9%
12,6290.0%0.00%
Q4 2021$101,000
-28.4%
12,6290.0%0.00%
Q3 2021$141,000
-23.4%
12,6290.0%0.00%
Q2 2021$184,000
-19.7%
12,6290.0%0.00%
Q1 2021$229,00012,6290.00%
Other shareholders
LANTERN PHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
CM Management, LLC 75,000$255,7500.27%
Redmond Asset Management, LLC 46,506$158,5850.06%
Pathway Financial Advisors LLC 32,771$111,7490.04%
CARLSON CAPITAL L P 95,000$323,9500.02%
NewEdge Advisors, LLC 170,031$579,8280.01%
WOLFF WIESE MAGANA LLC 2,200$7,5020.01%
Meridian Wealth Management, LLC 16,660$56,8110.00%
Sigma Planning Corp 18,125$61,8060.00%
HORIZON KINETICS ASSET MANAGEMENT LLC 30,000$102,3000.00%
WELLS FARGO & COMPANY/MN 4,492$15,3180.00%
View complete list of LANTERN PHARMA INC shareholders